CLINICAL_TRIALS
trial_result
· 2011-08-23
Clinical Trial Update: A Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) [Phase 2]
Summary
Phase 2 safety and tolerability study of ABT-089 in children with ADHD was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Abbott | Conditions: Attention-Deficit/Hyperactivity Disorder | Phase 2 | Status: TERMINATED